Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds UBS Downgrades Moelis & Co to Neutral, Lowers Price Target to $40

UBS Downgrades Moelis & Co to Neutral, Lowers Price Target to $40

UBS analyst Brennan Hawken downgrades Moelis & Co (NYSE:MC) from Buy to Neutral and lowers the price target from $54 to $40.

July 6, 2022

1 minute read

UBS analyst Brennan Hawken downgrades Moelis & Co (NYSE:MC) from Buy to Neutral and lowers the price target from $54 to $40.

Expert Ratings for Alimera Sciences

June 12, 10:03 AM

Within the last quarter, Alimera Sciences (NASDAQ:ALIM) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

January 20, 8:56 AM

Truist Securities analyst Andrew Jeffrey maintains Global Payments (NYSE:GPN) with a Buy and raises the price target from $120 to $135.

August 25, 3:51 PM

Telsey Advisory Group analyst Dana Telsey reiterated the Less Risk rating on Caleres, Inc. (NYSE: CAL)

August 22, 8:09 AM

Microsoft Corp (NASDAQ: MSFT) recently presented a revised proposal to purchase Activision Blizzard Inc (NASDAQ: ATVI) after U.K.